The Daily Briefing
Read the briefing
This is the Pulso Daily Briefing for October 22, 2026.
First, a profile. Sofia Delgado spent a decade in hospital pharmacy, then made a deliberate trade: fewer hours inside a system, more hours in direct consultation with patients. She rebuilt her work in stages over two years, pricing every service around time with the patient rather than volume. Her advice to clinicians considering the same move is procedural: model the income you are giving up before you give it up.
Next, technology. Ambient AI scribes are entering practices of every size, and pilot evaluations report documentation time falling by roughly a third to a half. The characteristic error is not invention. It is omission with confidence: a dropped negative finding, a laterality flip, a plan item noted that was discussed but never decided. Read the note before you sign it.
Finally, the evidence on creatine after fifty. Paired with resistance training, creatine outperforms training alone on lean mass and some strength measures. Without training, it does very little. The dose used in most trials is three to five grams of creatine monohydrate daily, and loading phases are optional.
That is the briefing. Our promise stands: a better version of yourself, the more you read.



